These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3144165)

  • 1. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
    Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
    Miles WM; Chang MS; Heger JJ; Rinkenberger RL; Zipes DP; Prystowsky EN
    Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
    Chimienti M; Li Bergolis M; Moizi M; Salerno JA
    J Am Coll Cardiol; 1989 Oct; 14(4):992-8. PubMed ID: 2507613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
    Akhtar M; Niazi I; Naccarelli GV; Tchou P; Rinkenberger R; Dougherty AH; Jazayeri M
    Am J Cardiol; 1988 Dec; 62(19):45L-49L. PubMed ID: 3144167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I; Naccarelli G; Dougherty A; Rinkenberger R; Tchou P; Akhtar M
    J Am Coll Cardiol; 1989 Mar; 13(4):904-10. PubMed ID: 2494243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
    Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
    Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic effects and efficacy of cibenzoline in patients with supraventricular tachycardia.
    Fujiki A; Mizumaki K; Tani M; Yoshida S; Sasayama S
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):375-9. PubMed ID: 1279281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
    Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous 3-methoxy-O-desmethyl-encainide in reentrant supraventricular tachycardia: a randomized double-blind placebo-controlled trial in patients undergoing EP study.
    Ware DL; Lee JT; Murray KT; Hanyok JJ; Roden DM; Echt DS
    Pacing Clin Electrophysiol; 1991 Sep; 14(9):1343-50. PubMed ID: 1720527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction.
    Derval N; Skanes AC; Gula LJ; Gray C; Denis A; Lim HS; Krahn AD; Yee R; Sacher F; Haïssaguerre M; Klein GJ
    Heart Rhythm; 2013 Dec; 10(12):1785-91. PubMed ID: 24076446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine sensitivity of retrograde fast pathway conduction in patients with slow-fast atrioventricular nodal reentrant tachycardia: a prospective study.
    Efimova E; Riahi S; Fiedler L; Esato M; Sommer P; Richter S; Breithardt O; Rolf S; Bollmann A; Hindricks G; Arya A
    Heart Rhythm; 2014 May; 11(5):871-6. PubMed ID: 24583097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
    Kühlkamp V; Mewis C; Mayer F; Seipel L
    Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The excitable gap in atrioventricular nodal reentrant tachycardia. Characterization with ventricular extrastimuli and pharmacologic intervention.
    Schuger CD; Steinman RT; Lehmann MH
    Circulation; 1989 Aug; 80(2):324-34. PubMed ID: 2752559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique electrophysiologic characteristics of atrioventricular nodal reentrant tachycardia with different ventriculoatrial block patterns: effects of slow pathway ablation and insights into the location of the reentrant circuit.
    Otomo K; Okamura H; Noda T; Satomi K; Shimizu W; Suyama K; Kurita T; Aihara N; Kamakura S
    Heart Rhythm; 2006 May; 3(5):544-54. PubMed ID: 16648059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.